Coresh, Josef
- Johns Hopkins University · Otolaryngology (NIH department code)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #1,451
- Sustained Excellence
- R01 Holder
- Long-Funded
- Top 10% Funded
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2001 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2023 award categories
- Otolaryngology
NIH Funding · FY2023
Linked Award Amount
$3.4M
Full award amounts, FY2023
Award Records
1
Records listing this PI
Award-Linked Rank
#1,451
By linked amount among FY2023 PIs
Earliest Year Loaded
2001
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Coresh, Josef as a PI. Multi-PI records show the full award amount for context.
- 5R01AG076518-02R01Contact PILong-term effects of hearing intervention on brain health in the Aging and Cognitive Health Evaluation in Elders (ACHIEVE) randomized studyJohns Hopkins University · Otolaryngology (NIH department code)$3.4Maward amount
Award organization
Organizations that administered FY2023 awards listing Coresh, Josef as a PI.
FY2023 award administered by Johns Hopkins University (MD).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2001First NIH AwardJohns Hopkins University
- 2001$500K Cumulative Funding
- 2001$1M Cumulative Funding
- 2001Entered Top 50% NationallyRanked #2908
- 2001Entered Top 25% NationallyRanked #2908
- 2002$2M Cumulative Funding
- 2005R01 Grant Holder
- 2015$5M Cumulative Funding
- 2017Entered Top 10% NationallyRanked #868
- 2017Entered Top 5% NationallyRanked #868
- 2018$10M Cumulative Funding
- 2022$25M Cumulative Funding